INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pharmacyclics Inc. of Commencement of Class Action Investigati...
March 09 2015 - 11:21AM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE
ACQUIRED COMMON STOCK OF PHARMACYCLICS INC. PRIOR TO MARCH 4, 2015 AND CONTINUE TO HOLD
SUCH SHARES.
YOU ARE HEREBY NOTIFIED that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of the
sale of Pharmacyclics Inc. (“Pharmacyclics”) (Nasdaq: PCYC) to
AbbVie (NYSE: ABBV) for $261.25 per share in cash and stock. To
learn more about the investigation and your rights, go to:
http://zlk.9nl.com/pharmacyclics-pcyc
There is no cost or obligation to you. Or contact Joseph
E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
(MM) (NASDAQ:PCYC)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:PCYC)
Historical Stock Chart
From Jul 2023 to Jul 2024